Fouda, S. M., & Bahgat, A. M. (2017). Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema. Clin Ophthalmol.
Chicago Style CitationFouda, Sameh Mosaad, i Ahmed M. Bahgat. "Intravitreal Aflibercept Versus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema." Clin Ophthalmol 2017.
Cita MLAFouda, Sameh Mosaad, i Ahmed M. Bahgat. "Intravitreal Aflibercept Versus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema." Clin Ophthalmol 2017.
Atenció: Aquestes cites poden no estar 100% correctes.